Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Trans Genic Inc

+ Add to Watchlist

2342:JP

418.0 JPY 0.00.00%

As of 02:00:00 ET on 04/24/2015.

Snapshot for Trans Genic Inc (2342)

Open: 418.0 Day's Range: 413.0 - 420.0 Volume: 56,000
Previous Close: 418.0 52wk Range: 388.0 - 546.0 1-Yr Rtn: -6.07%

Stock Chart for 2342

No chart data available.
  • 2342:JP 417.0
  • 1D
  • 1M
  • 1Y
418.0
Interactive 2342 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2342

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) -
Relative P/E vs. TPX -
Earnings Per Share (JPY) (ttm) -5.1360
Est. EPS (JPY) (03/2015) 0.7000
Est. PEG Ratio -
Market Cap (M JPY) 5,813.81
Shares Outstanding (M) 13.91
30 Day Average Volume 59,323
Price/Book (mrq) 2.2105
Price/Sale (ttm) 3.1874
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2342

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 2342

TRANS GENIC INC. develops, produces, and sells specific idiotype bearing antibody (bio reagent). The Company also develops mutant mice and sells mice' genetic function analysis data.

Kenji FukunagaPresidentKenichi YamamuraDirector
Tamami SakamotoDirectorYasushi FunabashiDirector
More Company Profile & Key Executives for 2342

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil